NOV vs Schlumberger
Add, change or remove companies; up to four.
KIRA’s take AI analyst
I put NOV and Schlumberger side by side, using each one’s latest annual report. Here is what stands out:
- Schlumberger is the larger business, with $35.7B of revenue in fiscal 2025 against $8.7B for NOV, about 4.1 times as much.
- Schlumberger turned more of its sales into free cash flow (13.4% FCF margin, against 10.0%).
- Schlumberger earned a higher return on the capital invested in it (12.7%, against 3.5%).
- Investors pay more for each dollar of NOV’s earnings: a P/E of 80.8x against 25.6x for Schlumberger.
Who comes out ahead
Of the 9 measures where higher (or lower) is clearly better, how many each company leads.
NOV
NOV
4/9
Revenue growthPiotroski F-scoreNet debt / EBITDAShare count change
Schlumberger
SLB
5/9
5-year growthNet marginFCF marginReturn on capitalReturn on equity
Side by side
Best in the row
| Latest fiscal year | NOV FY25 | SLB FY25 |
|---|---|---|
| Size | ||
| Market cap | $7.3B | $79.9B |
| Revenue | $8.7B | $35.7B |
| Free cash flow | $876M | $4.8B |
| Net income | $145M | $3.4B |
| Growth | ||
| Revenue growth | −1.4% | −1.6% |
| 5-year growth | 7.5% | 8.6% |
| Share count change | −5.3% | 0.1% |
| Profitability | ||
| Gross margin | 20.2% | — |
| Operating margin | 5.7% | — |
| Net margin | 1.7% | 9.5% |
| FCF margin | 10.0% | 13.4% |
| Return on capital | 3.5% | 12.7% |
| Return on equity | 2.3% | 14.3% |
| Balance sheet | ||
| Net debt | $428M | $5.5B |
| Net debt / EBITDA | 0.5x | 0.7x |
| Dividends and buybacks | $505M | $4.0B |
| Valuation & quality | ||
| P/E | 80.8x | 25.6x |
| Piotroski F-score | 5 | 4 |
Ten years
Revenue
Operating margin
Free cash flow
Return on capital
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.